Zero Candida Technologies, Inc. (FRA:9L2)

Germany flag Germany · Delayed Price · Currency is EUR
0.102
-0.016 (-13.56%)
At close: Dec 4, 2025
Market Cap 2.41M
Revenue n/a
Net Income n/a
Shares Out n/a
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.103
Previous Close 0.118
Day's Range 0.102 - 0.103
52-Week Range 0.096 - 0.983
Beta n/a
RSI 38.57
Earnings Date n/a

About Zero Candida Technologies

Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring. The company is headquartered in Vancouver, Canada. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Country Canada
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 9L2
Full Company Profile

News

There is no news available yet.